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1. Introduction
Biomineralization refers to the process of obtaining biominerals in living organisms, and can
be both a pathological and a non-pathological process [1]. This term was coined at the begin‐
ning of the eighties of the past century, and opened a new way of inspiring materials for
biomedical applications [2].
Nowadays, the understanding of many diseases, like gallbladder stones related to patholog‐
ical aspects of biominerals’ formation in living organisms, is based on the knowledge of the
chemical recognition between biological macromolecules, calcium salts and cholesterol mol‐
ecules [3-5]. This kind of chemical interaction has played an important role in the develop‐
ment of biologically inspired biosensors. A biosensor is an analytical device consisting of
two elements in spatial proximity: (1) a biological recognition element able to interact specif‐
ically with a target; (2) a transducer able to convert the recognition event into a measurable
signal [6].
According to the mechanism of biological signaling used, biosensors are classified into five
major types, one of them is the biomimetic one; in this sense, a biomimetic biosensor is an
artificial or synthetic sensor that mimics the function of a natural biosensor [7]. Some exam‐
ples of these types of sensors are the quercetin-modified wax-impregnated graphite elec‐
trode (Qu/WGE) for the purpose of detecting uric acid (UA) in the presence of ascorbic acid
© 2013 Bravo-Arredondo et al.; licensee InTech. This is an open access article distributed under the terms of
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(AA) [8]; a cell-based biosensor platform of neuron silicon interface with acid-sensing taste
receptor cells cultured on light addressable potentiometric sensor (LAPS) [9]; a Langmuir-
Blodgett film of tyrosinase incorporated in a lipidic layer with lutetium bisphthalocyanine
as an electron mediator for the voltammetric detection of phenol derivatives [10]; a mixed
self-assembled monolayers (SAMs) functionalized with specific olfactory receptors
(ODR-10) constructed on the sensitive area of surface acoustic wave (SAW) chip [11]. Re‐
cently, a new type of chemical biosensor based on intramineral proteins of eggshells for car‐
bonate ions detection has been published elsewhere [12].
The precipitation of the cholesterol and the calcium salts are commonly found in the bladder
(bile), whereas the calcium carbonate, which is the major component, is normally found in
the pancreas, at alkaline pH [13]. This formation usually follows the principles of crystal
growth and the simple chemical solubility rules. However, it has been recently observed
that the formation of gallstones or minerals of biogenic origin (grown in these biological
vesicles) leads the growth process in extreme conditions, even devoid of water in some cas‐
es. It is not clear whether some of the genes (mostly in mammals) could be involved in most
of the pathological processes, however, it has been proved the ethnical influence on the
medical diagnosis [14]. Recent publications have shown that there are genes already identi‐
fied (mainly in marine organisms) whose role in activating biomineralization processes has
been tested by molecular biology techniques [15]. Nowadays, the knowledge about the
genes involved in the formation of certain skeleton in marine spicules is, in general clearly
identified. However, our understanding of the role of any of the proteins in biomineraliza‐
tion is scarce, so is our understanding of the role of the matrix proteins as well as protein-
protein, and protein-mineral interaction [16].
Concerning the crystallization of cholesterol in human bile, there are some proteins from the
serum involved in this matter, the immunoglobulines IgM, IgA, IgG as well as the proteins
α1-Acid Glycoprotein (AAG, usually called Orosomucoid), Phospholipase C and Aminopep‐
tidase N. According to a recent publication, only three proteins from this list showed a po‐
tent enhancement and a promoting effect on the crystallization of cholesterol: IgM, IgA and
AAG protein [17]. Particularly, orosomucoid a protein of 42 kDa, is one of the most abun‐
dant proteins of serum proteins with no well-known physiological function. However, a
number of biological activities have been described for orosomucoid, such as promotion of
collagen fibril formation, inhibition of platelet aggregation, inhibition of heparin accelerated
antithrombin III mediated activation of thrombin and factor Xa, binding of Δ-4 Ketosteroids,
sequestration of a glycosaminoglycan cofactor in the lipoprotein lipase reaction and the
preferential binding of more than 60 cationic therapeutic drugs [18]. The orosomucoid pro‐
tein has an unusual pI of around 3 and an extraordinary carbohydrate content of approxi‐
mately 40% (w/w), comprising five N-linked glycans [19]. However, although the
importance of this orosomucoid in human physiology seems to be high, there are no more
structural data from the native glycoprotein obtained at high resolution. The orosomucoid
was firstly crystallized in 1984 [18], and since then no more structural data of that native gly‐
coprotein at high resolution have been published. The high-resolution crystallographic
structure was not available for a long time. However, the three-dimensional structure has
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been recently available at 1.8Å resolution of a recombinant AAG protein crystallized in a tet‐
ragonal P41212 space group. This recombinant human AAG produced as monomeric, yet un‐
glycosylated protein in E. coli was obtained via secretion into the bacterial periplasm, where
formation of its two-disulphide bonds was facilitated in the oxidizing environment [20]. The
former crystals of the native AAG protein were obtained in a hexagonal P622 or P6222 or the
enantiomorph P6422 space group in the presence of chlorpromazine at 18 °C [18]. Interested‐
ly, the co-crystallization of the tetragonal AAG by soaking method in the presence of the
well-known ligands (phenothiazine tranquilizers) like chlorpromazine, bromazepam or dia‐
zepam, failed [20]. This is due to the unglycosylated 3D structure. It seems that the carbohy‐
drates play an important role into the 3D structure-function of the native glycoprotein when
making the chemical recognition between this AAG protein and some common drugs.
In this  chapter  we evaluate,  from the electro-analytical  point  of  view, the plausible role
into  the  chemical  interaction  and  chemical  recognition  of  sodium  carbonate,  bilirubin,
cholesterol with α1-Acid Glycoprotein (AAG) usually found in biogenic minerals in bile.
Additionally, we show the effect of different gel media on the crystallographic habits of
synthetically  grown  crystals  of  cholesterol.  These  crystals  were  characterized  by  X-ray
powder diffraction. Finally, based on our results, we propose a new design of a biologi‐
cally inspired biosensor.
2. Experimental
Cyclic Voltammetry. All the electroanalytical assays to investigate the analyte-protein interac‐
tion for example, sodium carbonate, cholesterol, and bilirubin with the α1-Acid Glycoprotein
were performed using a Potentiostat/Galvanostat PG580 from UNISCAN Instruments (UK).
The potential was ranging from 0 to 1.80 Volts versus a Saturated Calomel Electrode (as a
reference electrode). The velocity for this electrochemical analysis was 50 mVs-1.
Figure 1. Electrochemical cell used for cyclic voltammetry experiments.
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Figure  1  shows  the  electrochemical  cell  used  for  this  determination.  Three  electrodes
were  used  along  the  experiments.  The  working  electrode  (5  mm diameter)  was  a  gold
microelectrode  Au10  from  Autolab  Electrochemical  Instruments  (USA).  The  auxiliary
electrode was a platinum wire of  0.5 mm in diameter.  The gold electrode was polished
using a diamond paste of 0.25 microns in particle size. The gold electrode was sonicated
several  times  in  order  to  remove  the  impurities.  The  auxiliary  electrode  was  cleaned
with a proper fine texture sandpaper to eliminate oxides on the surface. As an inert elec‐
trolyte  0.5M  Potassium  Chloride  (Strem  Chemicals,  Inc.  Newburyport,  Code  7447-40-7)
was used with a purity of 99.999%. The highly pure α1-Acid Glycoprotein (AAG protein)
was purchased from Sigma (Code G9885) without further purification. The electroanalyti‐
cal  plots,  as  those  shown in  Figure  2,  were  obtained taking into  account  the  gold elec‐
trode  saturation  for  each  scanning  cycle  as  well  as  removing  the  background from the
oxidation of gold at 1.3V. This value corresponds to a maximum peak into the anodic re‐
sponse  of  the  voltammogram  (right-hand  side  of  the  plot  current  versus  potential)  at
each  analyte  concentration.  This  AAG  protein  (50  μg)  was  absorbed  on  the  gold  elec‐
trode until the water was evaporated. For each analyte five different concentrations were
done as well as duplicates for each single concentration. The electrochemical experiment
is carried out until the analyte is put into contact with the protein and after an equilibri‐
um time of  2  minutes.  Before running any of  the experiments  the oxygen was degased
by  bubbling  pure  nitrogen  for  15  minutes.  All  dissolutions  were  prepared  in  a  glass
beaker  of  5  mL with  0.1,  0.2,  0.3,  0.4,  and 0.5  mM of  each  electroanalyte.  The  dissolu‐
tions were then transferred to the electrochemical cell. However, as bilirubin is not solu‐
ble in water, it had to be prepared in DMSO as follows: 2.92 mg were dissolved in 1 mL
of DMSO-Water 80:20 and keeping the solution away from oxidation inside of an amber
container.  Cholesterol  was  prepared dissolving 1.93  mg in  1  mL of  ethanol-water  80:20
and sealing it carefully to avoid any alcohol evaporation.
In  order  to  investigate  the  chemical  interaction  between  cholesterol  and  AAG  protein,
the cholesterol crystals were grown in different crystal growth media, solution, and two
types  of  hydrogels  in  the  Granada  Crystallization  Boxes  via  counter-diffusion  methods
[21]. In solution method, it was used an ethanol solution in the classic evaporation proc‐
ess;  and in  the gel  method tetramethyl  orthosilicate  (TMOS) hydrogel  was prepared by
polycondesation reaction [22],  and agarose hydrogel  was prepared by heating and cool‐
ing  method [23].  After  obtaining  the  gel  phase,  the  solution  of  cholesterol  0.5% w/v  in
ethanol was poured onto the top of each gel allowing cholesterol molecules to diffuse in‐
to  the  gel  network  for  one  week  at  18  °C.  After  this  week,  the  solution  was  removed
and  replaced  with  water  to  produce  the  crystal  growth  of  cholesterol  by  reducing  the
solubility in water, changing the dielectric constant.
X-ray powder diffraction. Cholesterol crystals were characterized by using an Empyrean
XRD system from PANalytical Instruments (Netherlands), into the following conditions: Cu
Kα radiation, monochromator, time step = 0.004s, step size = 19.68, 2θ = 4 to 50 deg, at room
temperature.
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3. Results and discussion
The cyclic voltammetry for AAG protein showed an anodic response when interacting with
carbonate, cholesterol and bilirubin (Figures 2a, 2b, and 2c). The protein alone did not show
any electrochemical response in an aqueous solution of KCl 0.5M (curve not shown). This
protein-substrate response was dependent of the concentration, and is characterized by an
increment of current with the sequential increment of the analyte concentration. Only two of
the three analytes (carbonate ions Figure 2a and bilirubin Figure 2c) investigated showed a
strong protein interaction with them and generated a characteristic plot with increments of
current. A small peak is observed at a potential value of 0.54 V, which corresponds to the
oxygen reduction of the small amount of water electrolysis that occurs during the electro‐
chemical response at E > 1.6 V. The peak is more evident for the cholesterol (Figure 2b) that
interacts in minor proportion with the protein. This behavior decreases the strength of the
interaction, which is almost imperceptible for bilirubin (Figure 2c). This demonstrates that
covered electrode with a stable protein-analyte layer generates a cleaner analytical signal
avoiding the water electrolysis as a parasite reaction.
In order to have a clearer visualization of the effect, the electrochemical response of the pro‐
tein was measured on the gold electrode without analyte (Io). Then this curve was used to
obtain a normalized plot I/Io, which allowed standardizing all the experiments respect to the
chemical interaction to the analyte (see Figure 3). The chemical interaction between the AAG
protein and the specific analytes can be detected by either a big difference between I/I0 or a
big change value on the slope. When obtaining the normalized plots as shown in Figure 3,
bilirubin showed the strongest chemical interaction, less intense followed by the carbonate
ions. This behavior is particularly interesting since most of the preliminary investigations
have claimed that AAG protein recognizes cholesterol molecules or works as a crystalliza‐
tion promoter in human bile, as that observed for different immunoglobulins like IgM, IgA,
IgM or for phospholipase C and aminopeptidase N [17], but according to these results the
interaction with bilirubin must not be discarded.
From these results it is clear that supersaturation of cholesterol in bile is a necessary condi‐
tion though not sufficient, for the formation of cholesterol gallstones [3]. Biliary proteins,
which are capable of affecting the rate at which cholesterol crystallization occurs, are impor‐
tant factors in pathogenesis of cholesterol gallstone diseases [3]. The pathway is as follows:
(1) AAG-bilirubin complex formation, (2) cholesterol nucleation and (3), cholesterol crystal
growth. The solubility of cholesterol is quite an interesting issue to take into account, when
trying to investigate this chemical recognition in vivo experiments. Cholesterol in vitro is
soluble in alcoholic solutions, but in vivo, cholesterol molecules should be solubilized by
aqueous micellar solution or transported either by apolipoproteins or by any other biomole‐
cules in order to make it soluble. The cholesterol can be crystallized inside the bile, or be se‐
creted to the blood stream or sent directly to the stools [4]. This process based on the
electrochemical observations, is in agreement with the enterohepatic circulation from the
liver to the bile [11]. In this physiological process bilirubin needs the chemical interaction
with cholesterol. Bilirubin is firstly conjugated with glucoronic acid in the liver by the en‐
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zyme glucuronyltransferase making it soluble in water, and perhaps with cholesterol too.
Therefore, it makes sense that the first crystals of AAG protein were obtained by Schmidt in
1952 using ethanol as precipitating agent [24]. The α1-Acid Glycoprotein is a cholesterol
crystallization promoter conjugated with a complex bilirubin-cholesterol as shown in the
electroanalytical results in Figure 2.
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Figure 2. a. Cyclic voltammogram of AAG – KCl / Na2CO3 ranging the carbonates concentration from 0.1 to 0.5 mM
scanning speed of 50 mVs-1. b. Cyclic voltammogram of AAG – KCl / Cholesterol ranging the cholesterol concentration
from 0.1 to 0.5 mM scanning speed of 50 mVs-1. c. Cyclic voltammogram of AAG – KCl/Bilirubin ranging the bilirubin
concentration from 0.1 to 0.5 mM scanning speed of 50 mVs-1
In humans, gallbladder sludge (gel-like media), a reversible pre-gallstone phase, consists of
cholesterol crystals and bilirubin granules in a mesh of mocus called mucin. Mucin a glyco‐
protein commonly observed in bile, is the constituent of the core and non-cholesterol matrix
of cholesterol gallstones. It is highly likely that gallbladder mucin is actively involved at a
number of stages in cholesterol precipitation [25].
On the other hand, calcium salts are present in all pigment gallstones as compounds of one
or more of the anions in bile: (i) carbonate; (ii) bilirubinate, and (iii) phosphate. In addition,
since cholesterol stones have been found to contain pigment stone centers, perhaps bilirubin
and AAG protein are complexed. We can postulate that the presence of calcium salts precip‐
itation in bile is a critical event in the initiation of cholesterol gallstones, so that the latter
should be considered a two-stage process: (i) precipitation of calcium salts chemically bond‐
ed to AAG protein to form a macromolecular complex plus some components of the bile, for
example mucin as a growth media, and then (ii) crystallization of cholesterol from its super‐
saturated state on this gel-like environment. It has been published that in vivo experiments
cholesterol precipitation starts with thin filamentous structures, which evolve into helical
and then tubular forms before breaking into characteristic flat cholesterol monohydrate
plates [26].
From the crystal growth point of view, the crystal habit of cholesterol grown in vitro and in
three different media (two of them hydrogels used to emulate mucin, a gel-like component
usually found in bile) shows the vicissitudes that a crystal goes through when growing (Fig‐
ure 4). The crystallographic faces, shown on each gel media, describe the plausible shapes
that cholesterol can display according to the transport and to the crystal growth processes,
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(the cholesterol keeps the same space crystallographic group). X-ray powder patterns of cho‐
lesterol lamellar-like crystals are shown in Figure 5. They have a good agreement with the
pattern reported in the Powder Diffraction File (PDF, file 7-742), which corresponds to the
triclinic phase, as well as those reported by several authors [26-28]. These cholesterol crys‐
tals should be grown in the presence of different combinations of AAG protein plus biliru‐
bin, in order to check the protein as a promoter (nucleant) of cholesterol molecules.
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Figure 3. Normalized plot (I/Io, see text for details) for anodic peaks corresponds to the maximum response of each
voltammogram AAG-KCl, at different molar concentration for each analyte: sodium carbonate, cholesterol and biliru‐
bin according to Figures 2a, 2b and 2c respectively.
Figure 4. Optical images of Cholesterol crystals grown in: A) Solution Ethanol/Water, B) Tetramethyl orthosilicate hy‐
drogel, C) Agarose hydrogel. The pictures (A) and (C) were taken between 90 degrees overcrossed-polarizers, while (B)
picture corresponds to unovercrossed-polarizers. Different scale bars are included as inset on each picture.
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Figure 5. X-ray powder diffraction characterization plots of cholesterol crystals grown in three different media: A) al‐
coholic solution by evaporation method, B) tetramethyl orthosilicate hydrogel, C) agarose hydrogel and D) X-ray dif‐
fraction pattern (PDF file No. 7-742) of a cholesterol of the triclinic phase P1.
In the near future, cholesterol crystals could be grown in the presence of bilirubin, glucoron‐
ic acid and most of the components of the bile extract, in order to see whether these crystals
will show the same crystallographic faces or not. These crystals could be re-dissolved in al‐
coholic solutions and the proteins extracted. These proteins could be purified and character‐
ized from the cholesterol crystals in order to check their similarity to the AAG protein.
Finally, the AAG protein should be co-crystallized in the presence of bilirubin-cholesterol
searching for the specific bonding-sites into the crystallographic structure either by X-ray
Crystallographic methods or by NMR, as performed in the crystallographic projects nowa‐
days. In future investigations we might be looking for inhibitors for the AAG Protein, like
the promising cholesterol antinucleating 120kDa glycoprotein found by Ohya et al. [29]; or
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look for strategies to turn the genes off related to the over-expression of this AAG protein in
vivo to control the cholesterol crystallization.
4. Biosensor’s design
From these electroanalytical results, the most plausible way of producing an ad hoc choles‐
terol-AAG/BR biosensor based on biological macromolecules like AAG, should follow the
steps from A to D as shown in the box-diagram of Figure 6. The first step (A) corresponds to
the gold electrode. The AAG protein would then be deposited on the gold electrode by us‐
ing a thin film of the protein, this is the second step called (B). In the following step, (C) the
protein should be complexed with bilirubin either by electrochemical interaction, or by
Langmuir-Blogget isotherms as proposed by Xie et al., [30]. Finally, (D) the amperometric
biosensor could be tested in the presence of different concentrations of alcoholic solutions of
cholesterol, based on the strategy described in the experimental set up on this contribution.
Figure 6. It shows different steps in order to produce an ad hoc Cholesterol-Bilirubin-AAG Biosensor.
The electrochemical response using this biosensor will be used to optimize the detection
limits to check cholesterol in different media either in solution or in gel (this latter which
would emulate the tissue texture or the mucin usually found in the bile).
5. Conclusions
We can observe from this research, that there is no a direct interaction between α1-Acid Pro‐
tein (AAG) and cholesterol molecules. The perfect biosensor for the evaluation of this chemi‐
cal interaction should take into account that bilirubin is the intermediate molecule between
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cholesterol, and the AAG protein. This protein works as promoter, but needs some inter‐
mediate molecules like bilirubin to solubilize cholesterol in aqueous solutions when precipi‐
tating gallstones. Future investigations should be focused on co-crystallizing these proteins
in the presence of bilirubin/cholesterol. The crystallographic 3D structure of the native gly‐
coprotein can give answers about the specific sites (amino acids), where cholesterol mole‐
cules could be attached to the protein molecule working as nucleation precursor.
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